Matinas BioPharma Holdings (MTNB) Cash & Equivalents (2013 - 2026)
Matinas BioPharma Holdings (MTNB) recorded Cash & Equivalents of $761,000 in Q2 2026, down 88.3% from $6.53 million a year earlier and down 68.3% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings reported Cash & Equivalents of $4 million, down 45.1% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -20.3% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $7.28 million in FY2024 (+52.2%), $4.79 million in FY2023 (-29.9%), $6.83 million in FY2022 (-67.5%) and $21.03 million in FY2021 (+69.2%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q2 2016.
- On a year-over-year basis, Cash & Equivalents has declined for four consecutive quarters, with growth averaging 58.5% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 546.5% in Q1 2025, against a decline of 88.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.4 million (Q1 2026), $4 million (Q4 2025) and $5.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Matinas BioPharma Holdings | 508,224.03 | -12.08 Mn | - | 761,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 761,000.00 |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 6.53 Mn |
| Mar 31, 2025 | 6.92 Mn |
| Dec 31, 2024 | 7.28 Mn |
| Sep 30, 2024 | 10.30 Mn |
| Jun 30, 2024 | 4.22 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 4.79 Mn |
| Sep 30, 2023 | 6.41 Mn |
| Jun 30, 2023 | 9.74 Mn |
| Mar 31, 2023 | 5.74 Mn |
| Dec 31, 2022 | 6.83 Mn |
| Sep 30, 2022 | 11.18 Mn |
| Jun 30, 2022 | 10.40 Mn |
| Mar 31, 2022 | 19.33 Mn |
| Dec 31, 2021 | 21.03 Mn |
| Sep 30, 2021 | 24.92 Mn |
API Access
Matinas BioPharma Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();